I believe you're right and frankly, it may depend on the

New Post Public Reply Private Reply Replies (1) Message Board
GaryM smarty72 #12753
415
I believe you're right and frankly, it may depend on the regulations in each of the countries they intend to market in. Here in the U.S., I believe they could market after proof of both safety, and an inspection of the production facility to assure it complies with manufacturing standards. I believe that Emilia is already producing product for them that meets commercial standards, and I believe that's why they keep saying that they have products that are market ready.

I believe the potential problem with Emilia's products may be whether cannabis products sold in a given State or Country must either be produced in that Country or State, or must be made with cannabis components from that country or State. Could you imagine the problems that would be created if every product sold in a Country or State had to be produced there. Right now the cannabis market is bogged down in such regulations, but hopefully it will change as cannabis gains acceptance.

I believe if you look at places like CVS, Costco, etc. you'll find all sorts of vitamins, minerals, supplements, etc that have undergone little or no clinical testing, but they're made of components that have been proven safe, and they're manufactured with equipment that meets manufacturing standards. Frankly if our cannabis cream could be marketed in the same way, Emilia could probably supply it anywhere it was permitted, but I believe at least initially it will be far more difficult than that, at least in some Countries and States.

One question in my mind is, would Emilia care to establish a manufacturing capability in each Country or State that demands product be manufactured there, or must OWCP in developing partnerships find partners who'll take full responsibility for manufacturing, in addition to distribution and sales.

I'm uncertain of just what Michelpro or Mediq's plans were wrt manufacturing, but to my knowledge, those companies have rights to European nations, and I'm uncertain what that will require. If we were speaking about small quantities, the equal of a compounding pharmacy might be sufficient to meet the demand, and perhaps that could be a starting point somewhere. As sales grew, however, it would be insane not to have mass production capability.

What we're facing is no different from any other cannabis based company selling products that go beyond what's removed from the plant.

I would love to see a partnership for here in California where the partner intended to build manufacturing capability here. With the 6th largest economy in the world, such a facility could certainly be justified. I'm not certain the same thing can be said for the other State's, and many of the Countries have economies smaller than California as well. Life would be so much easier if Emilia could provide product anywhere, but I don't know that's the case. I do believe that most companies aren't advanced to the point of having someone like Emilia to make their products, so we're ahead in that way.

Because I have no idea how our products are made, I don't know how difficult it would be for Emilia to mass produce all but the cannabis component in a given product at one place. Without the cannabis component they should be able to ship it anywhere in the world. If that's easily done, then putting a final production facility in each State or Country that requires it might not be too difficult.

Gary

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Smart Cooling Accessory: A Game Changer for AC Units?

Updated Category News Views 0

New Kid on the Block: The Smart Cooling Game They say the devil's in the details, and this one’s got all the right tweaks. Picture this — a compressor-based air conditioning system beefing up with a savvy accessory that promises to give your condenser coil some extra muscle. That's right, we've got ourselves a new contender in the cooling corner: THE CSC UNIT. It's...

Continue Reading
Nutex Health Scores Top Workplace Honor in 2026

Updated Category News Views 105

Nutex Health: Accolades and Aspirations Nutex Health just snagged something pretty noteworthy: They've been crowned a 2026 Houston Top Workplace by the Houston Chronicle. Now, before you start throwing confetti, let's chew on what this really means. It's no small potatoes, folks. We're talking employee respect and satisfaction measured by Energage’s surveys. It's proof...

Continue Reading
CHARMANT Eyewear Fuses Fashion and Functionality

Updated Category News Views 54

Eyewear ain’t just about seeing clearly anymore—it’s fashion with a capital ‘F’. The CHARMANT Japanese Made brand decided to foist this idea upon the world, putting their money where your eyeballs are, by injecting a dose of trendy glam into what they already do so well: comfort. Fusion of Style and Comfort Catch this: CHARMANT hit the global stage back in June...

Continue Reading
Human Development Fund's Bold Partnership for Growth

Updated Category News Views 54

An Unusual Alliance with Far-Reaching Implications Every once in a while, a nonprofit steps up with a move that makes even the toughest investors take notice. This isn't some Wall Street ticker talk, sure, but it’s worth turning your chair toward the table. The Human Development Fund (HDF) has penned a strategic deal with the Islamic Development Bank (IsDB), putting its...

Continue Reading
Millrose Faces Class Action Over Misleading Investors

Updated Category News Views 6

Millrose Properties Steps Into Legal Hot Water Ah, stocks and legal squabbles—a pairing as old as Wall Street itself. Now, folks, it seems Millrose Properties, Inc. has stepped right onto the chopping block with a lawsuit knocking on their door over claims they misled investors. The suits from the DJS Law Group aren't mince words: we're talking alleged violations of the...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 217

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Xinjiang Women Embrace New Horizons in Tianshan Peaks

Updated Category News Views 89

Scaling New Heights in Xinjiang Up there on the Tianshan Mountains, looking past those towering cliffs, what catches the eye isn't just breathtaking views but rising opportunities. In the land of Xinjiang, far from the bustling metropolises, young women are finding platforms to not just exist but to thrive. City by city, the narrative is changing as these women carve...

Continue Reading
Stocks Jump Ahead of Critical Inflation Reports

Updated Category News Views 41

Stocks Lift as Wall Street Awaits Inflation Data Every trader's favorite game—speculation—returns as major U.S. stock benchmarks kick off Monday with some gusto. The S&P 500, Nasdaq Composite, Dow Jones Industrial Average, and Russell 2000 all saw gains in the early morning session, signaling positive vibes across the board. Numbers don't lie, folks: The S&P climbed...

Continue Reading
Korean 'Glocal' Districts Entice U.S. Tourists with Local Flavor

Updated Category News Views 164

Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...

Continue Reading
Vinamilk's Optimum Gold Shines at Global Awards

Updated Category News Views 49

A Win Beyond Borders: Vinamilk's Global Recognition Sometimes, you gotta hand it to the underdog who comes out swinging and bags the big trophy. This time, it's Vinamilk's Optimum Gold nabbing the "Brand of the Year" at the World Branding Awards 2026-2027. Kicking open international doors from a quaint start in Vietnam to now shining under London's glittery skyline,...

Continue Reading

Top 5 Most Recently Viewed Articles

TGS ASA Engages Fixed Income Investors for Key Meetings

Updated Category News Views 137

TGS ASA Engages in Important Fixed Income Investor Meetings Oslo, Norway – TGS ASA, a pioneering force in energy data and intelligence, is preparing to engage with fixed income investors over a series of meetings. Scheduled to commence on a Monday, these meetings will see participation from notable institutions including J.P. Morgan, Danske Bank, and DNB Markets,...

Continue Reading
Man Group PLC's Disclosure on Urban Logistics REIT plc Holdings

Updated Category News Views 135

Understanding Man Group PLC's Recent Disclosure In the world of finance, transparency is key. This recent announcement from Man Group PLC serves as a public opening position disclosure concerning Urban Logistics REIT plc. It highlights the interests and positions held by a person in the relevant securities that are 1% or greater, adhering to Rule 8.3 of the Takeover Code....

Continue Reading
Understanding the Shift in Employer Attitudes Towards Talent

Updated Category News Views 221

Understanding the Shift in Employer Attitudes Towards Talent A recent survey unveiled significant insights into hiring practices and employer attitudes regarding overqualified candidates. Employers often welcome these candidates, yet they harbor deep concerns about retention and engagement, which leaves many job seekers feeling anxious. This changing perspective...

Continue Reading
GeneDx Reports Q4 Earnings: Analysts React with Price Cuts

Updated Category News Views 218

Unpacking the Earnings Surprise Can’t say I didn’t see that one coming. GeneDx (NASDAQ:WGS) drops some profits like it’s hot for Q4, clocking in earnings of 14 cents per share. That’s a solid beat compared to the 11-cent consensus the suits on Wall Street were whispering about. You can’t shake a stick at that, right? Well, not so fast—because the stock took a...

Continue Reading
Investing in Freeport-McMoRan: A 10-Year Perspective

Updated Category News Views 197

A Deep Dive into Freeport-McMoRan's Journey Alright, let’s cut to the chase. Freeport-McMoRan (NYSE: FCX)—this name's been buzzing on the trading floor for a while now. If you had put down $100 in FCX stock a decade ago, buckle up—your investment would be sitting pretty at about $859.11 today. That’s quite the leap, huh? In a market that shifts gears faster than a...

Continue Reading